Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Livio Luongo

Showing results (111-120 of 153) with videos related to

Pageof 16
Sort By:
Frontiers in Pharmacology|March 13, 2020
Treatment With 2-Pentadecyl-2-Oxazoline Restores Mild Traumatic Brain Injury-Induced Sensorial and Neuropsychiatric DysfunctionsSerena Boccella, Monica Iannotta, Claudia Cristiano, et al.
Frontiers in Pharmacology|March 22, 2017
Palmitoylethanolamide Reduces Neuropsychiatric Behaviors by Restoring Cortical Electrophysiological Activity in a Mouse Model of Mild Traumatic Brain InjuryFrancesca Guida, Serena Boccella, Monica Iannotta, et al.
Journal of Medicinal Chemistry|May 3, 2012
Design, synthesis, and pharmacological characterization of indol-3-ylacetamides, indol-3-yloxoacetamides, and indol-3-ylcarboxamides: potent and selective CB2 cannabinoid receptor inverse agonistsSerena Pasquini, Claudia Mugnaini, Alessia Ligresti, et al.
Bone|January 18, 2011
The endovanilloid/endocannabinoid system: a new potential target for osteoporosis therapyFrancesca Rossi, Giulia Bellini, Livio Luongo, et al.
Neuroscience Letters|May 11, 2017
d-Aspartic acid ameliorates painful and neuropsychiatric changes and reduces β-amyloid Aβ<sub>1-42</sub> peptide in a long lasting model of neuropathic painAntimo D'Aniello, Livio Luongo, Rosaria Romano, et al.
Neuropharmacology|February 16, 2023
Potential role of the hydroxyl carboxylic acid receptor type 2 (HCAR2) in microglia pathophysiology: A possible cross-talk with C-X-C chemokine receptor 1 (CXCR1)Michela Perrone, Martina Pagano, Carmela Belardo, et al.
Journal of Medicinal Chemistry|April 28, 2017
Exploring the Role of N<sup>6</sup>-Substituents in Potent Dual Acting 5'-C-Ethyltetrazolyladenosine Derivatives: Synthesis, Binding, Functional Assays, and Antinociceptive Effects in Mice ∇Riccardo Petrelli, Mirko Scortichini, Sonja Kachler, et al.
Pain|January 20, 2015
Selective melatonin MT2 receptor ligands relieve neuropathic pain through modulation of brainstem descending antinociceptive pathwaysMartha Lopez-Canul, Enza Palazzo, Sergio Dominguez-Lopez, et al.
The Journal of Clinical Endocrinology and Metabolism|June 14, 2016
Cannabinoid Receptor 2 as Antiobesity Target: Inflammation, Fat Storage, and Browning ModulationFrancesca Rossi, Giulia Bellini, Livio Luongo, et al.
ACS Chemical Neuroscience|February 5, 2020
Protective Effects of <i>N</i>-Oleoylglycine in a Mouse Model of Mild Traumatic Brain InjuryFabiana Piscitelli, Francesca Guida, Livio Luongo, et al.
Pageof 16

Showing results (111-120 of 153) with videos related to

Sort By:
Pageof 16
Frontiers in Pharmacology|March 13, 2020
Treatment With 2-Pentadecyl-2-Oxazoline Restores Mild Traumatic Brain Injury-Induced Sensorial and Neuropsychiatric DysfunctionsSerena Boccella, Monica Iannotta, Claudia Cristiano, et al.
Frontiers in Pharmacology|March 22, 2017
Palmitoylethanolamide Reduces Neuropsychiatric Behaviors by Restoring Cortical Electrophysiological Activity in a Mouse Model of Mild Traumatic Brain InjuryFrancesca Guida, Serena Boccella, Monica Iannotta, et al.
Journal of Medicinal Chemistry|May 3, 2012
Design, synthesis, and pharmacological characterization of indol-3-ylacetamides, indol-3-yloxoacetamides, and indol-3-ylcarboxamides: potent and selective CB2 cannabinoid receptor inverse agonistsSerena Pasquini, Claudia Mugnaini, Alessia Ligresti, et al.
Bone|January 18, 2011
The endovanilloid/endocannabinoid system: a new potential target for osteoporosis therapyFrancesca Rossi, Giulia Bellini, Livio Luongo, et al.
Neuroscience Letters|May 11, 2017
d-Aspartic acid ameliorates painful and neuropsychiatric changes and reduces β-amyloid Aβ<sub>1-42</sub> peptide in a long lasting model of neuropathic painAntimo D'Aniello, Livio Luongo, Rosaria Romano, et al.
Neuropharmacology|February 16, 2023
Potential role of the hydroxyl carboxylic acid receptor type 2 (HCAR2) in microglia pathophysiology: A possible cross-talk with C-X-C chemokine receptor 1 (CXCR1)Michela Perrone, Martina Pagano, Carmela Belardo, et al.
Journal of Medicinal Chemistry|April 28, 2017
Exploring the Role of N<sup>6</sup>-Substituents in Potent Dual Acting 5'-C-Ethyltetrazolyladenosine Derivatives: Synthesis, Binding, Functional Assays, and Antinociceptive Effects in Mice ∇Riccardo Petrelli, Mirko Scortichini, Sonja Kachler, et al.
Pain|January 20, 2015
Selective melatonin MT2 receptor ligands relieve neuropathic pain through modulation of brainstem descending antinociceptive pathwaysMartha Lopez-Canul, Enza Palazzo, Sergio Dominguez-Lopez, et al.
The Journal of Clinical Endocrinology and Metabolism|June 14, 2016
Cannabinoid Receptor 2 as Antiobesity Target: Inflammation, Fat Storage, and Browning ModulationFrancesca Rossi, Giulia Bellini, Livio Luongo, et al.
ACS Chemical Neuroscience|February 5, 2020
Protective Effects of <i>N</i>-Oleoylglycine in a Mouse Model of Mild Traumatic Brain InjuryFabiana Piscitelli, Francesca Guida, Livio Luongo, et al.
Pageof 16